Anxiety Sensitivity Program for Smoking Cessation
Not Applicable
Completed
- Conditions
- Smoking Cessation
- Interventions
- Behavioral: Anxiety Sensitivity Program for Smoking Cessation
- Registration Number
- NCT00387049
- Lead Sponsor
- University of Vermont
- Brief Summary
The purpose of this study is to develop and test a smoking cessation intervention for persons who are specifically sensitive to anxiety and anxiety-related bodily sensations.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
- Aged between 18 and 65 years old
- Not pregnant
- Regular smoker averaging 10 or more cigarettes per day for at least one year
- Score of 25 or greater on 16-item Anxiety Sensitivity Index
- Motivation to Quit score of 7 or greater (using Readiness to Quit Ladder)
- Not currently using pharmacotherapy for smoking cessation (e.g., Zyban)
- No use of other tobacco products (e.g., chewing tobacco, cigars)
- No Axis-I or Axis-II diagnoses other than mood or anxiety disorders (intake interview required)
- No suicidal or homicidal ideation
- No current psychotropic medication use
- No evidence of substance abuse or dependence (other than nicotine dependence)
- No history of significant medical conditions (cardiovascular, neurological, etc.)
- Ability to provide informed, written consent (no evidence of limited mental capacity)
- Sufficient command of the English language (able to carry on interview conversation)
- Plan to stay in Burlington VT area for at least next 6 months
Read More
Exclusion Criteria
- Not between 18-65 years old
- Pregnant or currently trying to become pregnant
- Regular smoker for less than one year OR smoke less than 10 cigarettes per day
- ASI below cutoff level of 25
- Motivation to Quit score of 6 or less (using Readiness to Quit Ladder)
- Current or recent use of any pharmacotherapy for smoking cessation (e.g., patch, Zyban)
- Current use of other tobacco products (e.g., chewing tobacco, cigars)
- Axis-I disorders other than anxiety or mood disorders.
- Endorsement of suicidality or homicidal ideation.
- Any current psychotropic medication use (must have stopped at least 1 month prior).
- Any evidence of substance abuse or dependence (other than nicotine dependence)
- Any history of significant medical conditions (cardiovascular, neurological, etc.)
- Inability to provide informed, written consent (evidence of limited mental capacity)
- Insufficient command of the English language (unable to carry on conversation)
- Plan to permanently leave Burlington area anytime during the next 6-12 months
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Anxiety-specific smoking cessation care Anxiety Sensitivity Program for Smoking Cessation - Standard smoking cessation care Anxiety Sensitivity Program for Smoking Cessation -
- Primary Outcome Measures
Name Time Method Smoking status 24 weeks post Quit Day
- Secondary Outcome Measures
Name Time Method Where applicable, length of time from Quit Day to relapse. Determined at conclusion of study
Trial Locations
- Locations (1)
University of Vermont
🇺🇸Burlington, Vermont, United States